Glycation and oxidation of human low density lipoproteins reduces heparin binding and modifies charge

References

• Sparrow C P, Parthasarathy S, Steinberg D. A macrophage receptor that recognized oxidized low density lipoproteins but not acetylated low density lipoproteins. J Bio. Chem 1989; 264: 2599–604
   Google Scholar
• Vlassara H, Brownlee M, Cerami A. Nonenzymatic glycosylation: Role in the pathogenesis of diabetic complications. Clin Chem 1986; 32: B37–B41
   PubMed Web of Science ®Google Scholar
• Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988; 318: 1315–21
   PubMed Web of Science ®Google Scholar
• Kortlandt W, Benschop C, van Rijn H, Erkelens D. Glycated low density lipoprotein catabolism is increased in rabbits with alloxan-induced diabetes mellitus. Diabetologia 1992; 35: 202–7
   Google Scholar
• Gonen B, Baezinger J, Schonfeld G, Acobson D, Farner P. Nonenzymatic glycosylation of low density lipoprotein in vitro. Effects on cell-interactive properties. Diabetes 1981; 30: 875–78
   PubMed Web of Science ®Google Scholar
• Sasaki J, Cottam G L. Glycosylation of human low density lipoprotein and its metabolism in human skin fibroblasts. Biochem Biophys Res Commun 1982; 104: 983–97
   Google Scholar
• Schleicher E, Olgemoller B, Schon J, Durst T, Wieland O H. Limited nonenzymatic glycosylation of low density lipoprotein does not alter its catabolism in tissue culture. Biochem Biophys Acta 1985; 846: 226–33
   Google Scholar
• Witztum J L, Mahoney E M, Branks M J, Fisher M, Elam R, Steinberg D. Nonenzymatic glycosylation of low density lipoprotein alters its biologic activity. Diabetes 1982; 31: 283–91
   PubMed Web of Science ®Google Scholar
• Curtiss L K, Witztum J L. Plasma apolipoproteins AI, All, B, CI and E are glycosylated in hyperglycemic diabetic subjects. Diabetes 1985; 34: 452–61
   PubMed Web of Science ®Google Scholar
• Lopes-Virella M T, Klein R, Lyons T J, Stevenson H C, Witztum J L. Glycosylation of low density lipoprotein enhances cholesteryl ester synthesis in human monocyte-derived macrophages. Diabetes 1988; 37: 550–57
   PubMed Web of Science ®Google Scholar
• Arai H, Kita T, Yokode M, Narumiya S, Kawai C. Multiple receptors for modified low density lipoproteins in mouse peritoneal macrophages: different uptake mechanisms for acetylated and oxidized low density lipoproteins. Biochem Biophys Res Commun. 1989; 153: 1375–82
   Google Scholar
• Aviram M. The contribution of the macrophage receptor for oxidized LDL to its cellular uptake. Biochem Biophys Res Commun 1991; 179: 359–65
   PubMed Web of Science ®Google Scholar
• Aviram M, Bierman E L, Chait A. Modification of low density lipoproteins by lipoprotein lipase or hepatic lipase induces enhanced uptake and cholesterol accumulation in cells. J Biol Chem 1988; 263: 15416–22
   PubMed Web of Science ®Google Scholar
• Avogaro P, Bittolo Bon G, Cazzolato G. Presence of a modified low density lipoprotein in humans. Arteriosclerosis 1988; 8: 79–87
   PubMedGoogle Scholar
• Baynes J W. Role of oxidative stress in development of complications in diabetes. Diabetes 1991; 40: 405–11
   PubMed Web of Science ®Google Scholar
• Kjellen L, Linhall U. Proteoglycans: structures and interactions. Annu Rev Biochem 1991; 60: 443–75
   PubMed Web of Science ®Google Scholar
• Iverius P H. The interaction between human plasma lipoproteins and connective tissue glycosaminogly-cans. J Biol Chem 1971; 247: 2607–13
   Google Scholar
• Cardin A D, Randall C J, Hirose N, Jackson R L. Physical-chemical interaction of heparin and human plasma low density lipoproteins. Biochemistry 1987; 26: 5513–18
   Google Scholar
• Weisgraber K H, Rail S C. Human apolipoprotein B-100 heparin-binding sites. J Biol Chem 1987; 262: 11097–103
   PubMed Web of Science ®Google Scholar
• Schumaker V N, Puppione D L. Sequential flotation ultracentrifugation. Methods Enzymol 1986; 128: 155–70
   PubMed Web of Science ®Google Scholar
• Fischer W R, Schumaker V N. Isolation and characterization of apo B 100. Methods Enzymol 1986; 128: 247–62
   Google Scholar
• Gugliucci Creriche A, Stahl A JC. In vitro glycation of human apolipoprotein AI reduces its efficiency in lecithinxholesterol acyltransferase activation. Clin Chim Acta 1991; 204: 37–42
   Google Scholar
• Basu S K, Goldstein J L, Anderson R G, Brown M S. Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts. Proc Natl Acad Sci 1976; 73: 3178–81
   PubMed Web of Science ®Google Scholar
• Shaklai N, Garlick R L, Bunn F. Nonenzymatic glycosylation of human serum albumin alters its conformation and function. J Biol Chem 1984; 259: 3812–17
   PubMed Web of Science ®Google Scholar
• Baker J R, Metcalf P A, Johnson K N, Newman D, Rietz P. Use of protein-based standards in automated colorimetric determinations of fructo-samine in serum. Clin Chem 1985; 31: 1550–54
   PubMedGoogle Scholar
• Esterbauer H, Chelseman K. Determination of aldehydic lipid peroxidation products; malon-aldehyde and 4-hydroxynonenal. Methods Enzymol 1990; 186: 407–21
   PubMed Web of Science ®Google Scholar
• Jain S K, McVie R, Duett J, Herbst J J. Erythrocyte membrane lipid peroxidation and glycosylated hemoglobin in diabetes. Diabetes 1989; 38: 1539–43
   PubMed Web of Science ®Google Scholar
• Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248–25
   PubMed Web of Science ®Google Scholar
• Shinano H, Yamada N, Ishibashi S, Mokuno H, Mori N, Gotoda T, Harada K, Akanuma Y, Murase T, Yazaky Y. Oxidation labile subfraction of human plasma low density lipoprotein isolated by ion-exchange chromatography. J Lipid Res 1991; 32: 763–73
   Google Scholar
• Gugliucci Creriche A, Dumont S, Siffert J C, Stahl A JC. In vitro glycated low density lipoprotein interaction with human monocyte-derived macrophages. Res Immunol 1992; 143: 17–23
   Google Scholar
• Brownlee M, Vlassara H, Cerami A. Inhibition of heparin-catalyzed human antithrombin III activity by nonenzymatic glycosylation: possible role in fibrin deposition in diabetes. Diabetes 1984; 33: 533–35
   Google Scholar
• Hall P K, Roberts R C. Phosphate promotes glycation of antithrombin III which interferes with heparin binding. Biochim Biophys Acta 1989; 993: 217–23
   Google Scholar